Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 20.52% vs 12.22% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is -74.06% vs 17.02% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is -29.55% vs 17.97% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 16.33% vs -17.70% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Jubilant Pharmo With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 6.31% vs -2.65% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 20.52% vs 12.22% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -44.78% vs -52.68% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -74.06% vs 17.02% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -3.02% vs -26.91% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -29.55% vs 17.97% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 7.75% vs -4.07% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 16.33% vs -17.70% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025